Matthew Frank: Clinical Trials

1 trial sponsored by Matthew Frank, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Matthew Frank: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Fludarabine, Cyclophosphamide, CD22 CAR - B-ALL, B-cell Non Hodgkin Lymphoma
Phase 1CompletedMatthew Frank522019-09-122026-03-30

Conditions studied

Lymphoma, B-Cell (1)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Countries

United States (1)

Results publications

PMID 33512414, PMID 38996463

NIH funding

K08CA248968 (1)